BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 10.35 Delayed Data As of Jan 30 |  -0.235 / -2.22%Today’s Change | 7.61 Today|||52-Week Range 19.99 | -9.89% Year-to-Date |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 10.58 |
| Today’s open | 10.55 |
| Day’s range | 10.31 - 10.57 |
| Volume | 49,560 |
| Average volume (3 months) | 2,724,292 |
| Market cap | $2.0B |
Data as of 4:00pm ET, 01/30/2023
Growth & Valuation
| Earnings growth (last year) | +5.98% |
| Earnings growth (this year) | -8.09% |
| Earnings growth (next 5 years) | +74.32% |
| Revenue growth (last year) | +782.38% |
| P/E ratio | NM |
| Price/Sales | 15.78 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TLRYTilray Brands Inc | -0.13 | -4.21% |
| XNCRXencor Inc | -0.81 | -2.49% |
| ---- | ||
| RCKTRocket Pharmaceutica... | -0.99 | -4.45% |
Data as of 4:00pm ET, 01/30/2023
Financials
| Next reporting date | February 28, 2023 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $157.2M |
| Annual profit (last year) | -$184.1M |
| Net profit margin | -117.11% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
